Older men on testosterone therapy were less likely to experience complications requiring hospital readmission within 1 month of discharge than men not using testosterone therapy, according to a study published in Mayo Clinical Proceedings.
Testosterone deficiency has been linked to muscle loss and decline in overall health, placing older men with low testosterone at risk for “post-hospital syndrome.” Increased rates of hospital and long-term care facilities readmission have been seen in previous studies as well as death.
Researchers from the University of Texas Medical Branch at Galveston evaluated SEER-Medicare linked data on 6,372 men over age 66 with low testosterone who were hospitalized at least once between January 2007–December 2012. They analyzed patients’ risk of hospital readmission within 30 days of discharge.
The data showed older men receiving testosterone therapy were less likely to be readmitted within 30 days of discharge than men that did not receive testosterone therapy (9.8% vs. 13%). The decrease was more pronounced for emergency readmissions in men who received testosterone therapy (6.2%) vs. men who did not receive testosterone therapy (10%).
Findings suggest that a benefit of androgen therapy may be faster recovery and decreased rates of readmission, study author Jacques Baillargeon, concluded.
For more information visit utmb.edu.